Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable sensors could spot patient decline earlier than standard checks

NCT ID NCT07690267

Knowledge-focused Sponsor: University Hospital, Akershus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study looks at whether using wearable sensors to continuously monitor vital signs in a hospital surgical ward can improve patient safety compared to standard intermittent checks. Researchers will track patient outcomes like emergency team calls and unplanned intensive care transfers, and also survey nursing staff about safety culture and their experiences with the new monitoring system. The study includes about 9,600 patients and healthcare workers in a Norwegian hospital.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Continuous vital sign monitoring (CVSM) using wearable sensors
What this could lead to
If successful, this could show that continuous monitoring helps detect patient deterioration earlier than standard checks, potentially improving safety in hospital wards.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove cause and effect. The intervention is already in use, and findings may not apply to other hospitals or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 9,600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes adult patients admitted to a gastro-surgical ward before and after implementation of continuous vital sign monitoring (CVSM), as well as adult patients admitted to a non-equivalent comparison ward at the same Norwegian teaching hospital. The study population also includes healthcare professionals working in these wards.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years or older admitted to the gastro-surgical ward. * Healthcare professionals aged 18 years or older employed in the participating wards for survey participation. * Nursing staff with at least 6 months of work experience and experience using CVSM for participation in qualitative focus group interviews. Exclusion Criteria: * Patients with delirium. * Patients with cognitive impairment interfering with sensor use. * Patients who decline participation. * Patients with allergy to electrode adhesives.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Continuous vital sign monitoring are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Continuous vital sign monitoring Employee motivation Healthcare professionals Implementation Implementation research NURSES Patient deterioration Patient monitoring Patient safety Patient safety culture Telemonitoring Wearable devices Work-related outcomes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Akershus University Hospital HF

    RECRUITING

    Lørenskog, Akershus, 1478, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.